How to diagnose lymphoplasmacytic lymphoma without infiltration of plasmacytoid lymphocytes?
figure
The expression of multiple cancer/testis antigens can potentially be used to detect circulating disease and clonal evolution in the peripheral blood of multiple myeloma patients
figure
Development and validation of a comorbidity index for predicting survival outcomes after allogeneic stem cell transplantation in adult patients with acute leukemia: a Korean nationwide cohort study
figure
Blood Res 2021; 56(3): 125~207
Image of Hematologys
How to diagnose lymphoplasmacytic lymphoma without infiltration of plasmacytoid lymphocytes?
Ali El Kassir, Laetitia Largeaud, Inès Vergnolle et al.
Blood Res 2021; 56(3): 125-125  https://doi.org/10.5045/br.2021.2021098 PDF PubMed Central
Green-blue intracytoplasmic inclusions in the bone marrow in severe COVID-19
Elpiniki Kritikou-Griva, Ioulia Chaliori, Nikolaos J. Tsagarakis et al.
Blood Res 2021; 56(3): 126-126  https://doi.org/10.5045/br.2021.2021077 PDF PubMed Central
Plasma cells in disguise: the masquerader in hematopathology
Richa Juneja, Karthika Kundil Veetil, Haraprasad Pati
Blood Res 2021; 56(3): 127-127  https://doi.org/10.5045/br.2021.2021051 PDF PubMed Central
T cell acute lymphoblastic leukemia with t(11;14)(p13;q11) and trisomy 8
Moeinadin Safavi, Alieh Safari Sharari
Blood Res 2021; 56(3): 128-128  https://doi.org/10.5045/br.2021.2021059 PDF PubMed Central
Perspective
Platelet count as an important prognostic factor for vaccine-induced immune thrombotic thrombocytopenia
Soo-Mee Bang, M.D., Ph.D. et al.
Blood Res 2021; 56(3): 129-133  https://doi.org/10.5045/br.2021.2021126 PDF PubMed Central
Original Articles
Bendamustine in combination with ifosfamide, etoposide, and vinorelbine (VIBE) is an effective salvage regimen for heavily pre-treated patients with relapsed or refractory Hodgkin lymphoma: a single-center experience
Gaurav Prakash, Arihant Jain, Kamalkant Sahu et al.
Blood Res 2021; 56(3): 134-140  https://doi.org/10.5045/br.2021.2021039 PDF PubMed Central
Clinical Analysis of Hospitalized Patients with Hemophilia A: Single-hemophilia Treatment Center Experience in Korea over 10 years
Ju Young Kim, Se Jin Park, Chur Woo You
Blood Res 2021; 56(3): 141-149  https://doi.org/10.5045/br.2021.2020289 PDF PubMed Central
New cut-off point for D-dimer in the diagnosis of pulmonary embolism during pregnancy
Somayeh Sadeghi, Marjan Golshani, Bahareh Safaeian
Blood Res 2021; 56(3): 150-155  https://doi.org/10.5045/br.2021.2021069 PDF PubMed Central
Original Articles
The expression of multiple cancer/testis antigens can potentially be used to detect circulating disease and clonal evolution in the peripheral blood of multiple myeloma patients
Karen Shires, Teagan Van Wyk, Kirsty Wienand
Blood Res 2021; 56(3): 156-165  https://doi.org/10.5045/br.2021.2020335 PDF PubMed Central
Causes of erythrocytosis and its impact as a risk factor for thrombosis according to etiology: experience in a referral center in Mexico City
Antonio Olivas-Martinez, Eduardo Corona-Rodarte, Adrián Nuñez-Zuno et al.
Blood Res 2021; 56(3): 166-174  https://doi.org/10.5045/br.2021.2021111 PDF PubMed Central
Impact of timely BCR-ABL1 monitoring before allogeneic stem cell transplantation among patients with BCR-ABL1-positive B-acute lymphoblastic leukemia
Siew Lian Chong, Asral Wirda Ahmad Asnawi, Tze Shin Leong et al.
Blood Res 2021; 56(3): 175-183  https://doi.org/10.5045/br.2021.2021045 PDF PubMed Central
Development and validation of a comorbidity index for predicting survival outcomes after allogeneic stem cell transplantation in adult patients with acute leukemia: a Korean nationwide cohort study
Sung-Soo Park, Hee-Je Kim, Tong Yoon Kim et al.
Blood Res 2021; 56(3): 184-196  https://doi.org/10.5045/br.2021.2021107 PDF PubMed Central
Letters to the Editor
Clinical course of COVID-19 in a patient with refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) under ibrutinib therapy: a case report
Karin Zattar Cecyn, Mariana Oliveira Marques, Milena Almendra Rodrigues et al.
Blood Res 2021; 56(3): 197-201  https://doi.org/10.5045/br.2021.2020181 PDF PubMed Central
Ruxolitinib-induced extreme thrombocytosis in a COVID-19 patient
Víctor Manuel Anguiano-Álvarez, José Antonio Maza-Larrea, Francisco Javier Rosado-Hernández et al.
Blood Res 2021; 56(3): 201-202  https://doi.org/10.5045/br.2021.2020245 PDF PubMed Central
Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study
Chang Hyun Nam, Ja Min Byun, Dong-Yeop Shin et al.
Blood Res 2021; 56(3): 202-204  https://doi.org/10.5045/br.2021.2021067 PDF PubMed Central
Management of COVID-19-related immune thrombocytopenia by rhTPO
Xuzhao Zhang, Min Li, Tao Chen et al.
Blood Res 2021; 56(3): 205-207  https://doi.org/10.5045/br.2021.2020049 PDF PubMed Central

Current Issue

30 September 2021 Volume 56.
Number 3 pp. 125~207
ba_link01

SCImago Journal & Country Rank

Today : 45  /
Total : 368,371